These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 36447292)
1. Response to the letter by de Boer et al. (2022). Kaivola K; Tienari PJ Acta Neuropathol Commun; 2022 Nov; 10(1):173. PubMed ID: 36447292 [No Abstract] [Full Text] [Related]
2. Clinical Update on C9orf72: Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, and Beyond. Saracino D; Le Ber I Adv Exp Med Biol; 2021; 1281():67-76. PubMed ID: 33433869 [TBL] [Abstract][Full Text] [Related]
3. Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis. Katzeff JS; Bright F; Phan K; Kril JJ; Ittner LM; Kassiou M; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS Brain; 2022 Jun; 145(5):1598-1609. PubMed ID: 35202463 [TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582 [TBL] [Abstract][Full Text] [Related]
5. C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis. Fredi M; Cavazzana I; Biasiotto G; Filosto M; Padovani A; Monti E; Tincani A; Franceschini F; Zanella I Neuromolecular Med; 2019 Jun; 21(2):150-159. PubMed ID: 30859373 [TBL] [Abstract][Full Text] [Related]
9. C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia: gain or loss of function? Mizielinska S; Isaacs AM Curr Opin Neurol; 2014 Oct; 27(5):515-23. PubMed ID: 25188012 [TBL] [Abstract][Full Text] [Related]
10. Molecular Mechanisms of Neurodegeneration Related to Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737 [TBL] [Abstract][Full Text] [Related]
11. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)]. Tomiyama H Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305 [TBL] [Abstract][Full Text] [Related]
12. Cerebellar integrity and contributions to cognition in C9orf72-mediated frontotemporal dementia. Chen Y; Landin-Romero R; Kumfor F; Irish M; Dobson-Stone C; Kwok JB; Halliday GM; Hodges JR; Piguet O Cortex; 2022 Apr; 149():73-84. PubMed ID: 35189395 [TBL] [Abstract][Full Text] [Related]
13. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort. Van Mossevelde S; van der Zee J; Gijselinck I; Engelborghs S; Sieben A; Van Langenhove T; De Bleecker J; Baets J; Vandenbulcke M; Van Laere K; Ceyssens S; Van den Broeck M; Peeters K; Mattheijssens M; Cras P; Vandenberghe R; De Jonghe P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C; Brain; 2016 Feb; 139(Pt 2):452-67. PubMed ID: 26674655 [TBL] [Abstract][Full Text] [Related]